# SBI Asset Management

> SBI Asset Management is a VC fund in Tokyo backing FinTech and Medical. See 4 investments, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tokyo, Japan
- Total investments: 4
- Last investment: Aug 2023
- Lead investor: 0%
- Last updated: Aug 2026
- X (Twitter): https://www.twitter.com/sbi_am
- Website: http://www.sbiam.co.jp
- Facebook: https://www.facebook.com/sbiamexei

SBI Asset Management is a VC fund in Tokyo focused on FinTech and Medical. The greater sophistication and diversity of investors' asset management needs requires management firms to offer, in a timely manner, products that meet the needs of a wide range of investors. SBI Asset Management leverages its position as an independent management company, and utilizes domestic and overseas resources, to offer not justconventional financial products, such as domestic and overseas stocks and bonds, but alternative investment products as well, including unlisted stocks and hedge funds.They have selected only quality hedge funds from more than 8,000 that exist worldwide to offer attractive investment opportunities that meet investor needs.They continue to offer domestic and overseas hedge fund investment through domestic investment trust.They also work to ensure timely and easy-to-understand disclosure as they understand that a major pitfall preventing investment in hedge funds is their closed nature and complexity.SBI Asset Management provides a variety of value-added and professional services for investors, including investment management, investment advice management, foreign investment trust management for overseas subsidiaries, and securities investment corporation management.Through innovative thinking and hard work, SBI Asset Management continuously strive to be the best management firm for every investor they serve.

## Contacts

5 contacts available for SBI Asset Management. Shizune tracks 4 team members at SBI Asset Management. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/sbi-asset-management?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| FinTech | 2 | 50% |
| Medical | 2 | 50% |
| Finance | 1 | 25% |
| Genetics | 1 | 25% |
| Hospital | 1 | 25% |

16 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 25% |
| Series B | 1 | 25% |
| Series H | 1 | 25% |
| Funding Round | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| India | 1 | 25% |
| South Korea | 1 | 25% |
| United States | 1 | 25% |
| United Kingdom | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Kazuyuki Matsui | Director | 0 | — |
| Kenji Hirai | Executive Director | 0 | — |
| Takashi Nakagawa | Director | 0 | — |
| Yoshitaka Kitao | Director | 0 | — |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Jupiter Hospital | Jupiter Hospital specializes in cancer care, cardiology, paediatrics, organ transplantation, haematology, nephrology and orthopaedics. | $14.3M |  | Aug 22, 2023 |  |
| CompareEuropeGroup | CompareEuropeGroup is a financial comparison platform for insurance, banking, and telco products, such as car insurance, personal loans, credit cards, and broadband subsriptions.The company operates the leading online comparison platforms for financial, TELCO and utility products across Europe. Created with the purpose of helping consumers tosave time and money, the platform offers a free and easy market comparison across 600 products, along with a simple application process. CompareEuropeGroup’s core values including complete transparency, independence and trust, along with a commitment to building the most convenient, comprehensive and educational platforms available. | $21.9M | Series A | Jan 11, 2017 |  |
| Coinplug | Coinplug is a blockchain developing company leading the next generation of blockchain-based solutions and services, being a pioneer in the field since its founding in 2013 and with over 300 blockchain patents. The company is continuously innovating in the field of blockchain, focusing in the areas of Identity & Authentication (DecentralizedIdentity, Self-Sovereign Identity), Payment Solutions and Assets Management. | $5M | Series B | Oct 02, 2015 |  |
| Quark Pharmaceuticals | Founded in 1994, Quark devoted its early years to developing its innovative technology platform for identification of novel functional target genes and proteins, the “BiFAR” technology. The basic concept, patented by Quark, of high throughput gene inactivation combined with microarray detection of the functional genes responsible for theoccurrence of phenotypes of interest, was at that time revolutionary. With the advent of siRNA technology, Quark's approach is rapidly becoming the technology of choice for functional studies industry-wide. We have applied our BiFAR platform in gene discovery programs in serious diseases with significant unmet medical needs, often in collaboration with large pharmaceutical partners. Today we are harvesting the fruits of the innovative targets and concepts we identified. | $13.9M | Series H | Apr 18, 2008 |  |

4 of 4 investments shown.

## Co-investors
- [ACE & Company](https://shizune.co/investors/profile/ace-and-company) — VC Fund, 1 deal together
- Ashoka India Equity Investment Trust — VC Fund, 1 deal together
- [Atinum Partners](https://shizune.co/investors/profile/atinum-investment) — VC Fund, 1 deal together
- [Founders Fund](https://shizune.co/investors/profile/founders-fund) — VC Fund, 1 deal together
- [360 ONE Asset](https://shizune.co/investors/profile/iifl-asset-management) — VC Fund, 1 deal together
- [KB Investment](https://shizune.co/investors/profile/kbinvest) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does SBI Asset Management invest in?

SBI Asset Management invests primarily in FinTech, Medical and Finance startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact SBI Asset Management?

Public channels for SBI Asset Management include X (Twitter), the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at SBI Asset Management?

The team at SBI Asset Management includes Kazuyuki Matsui (Director), Kenji Hirai (Executive Director) and Takashi Nakagawa (Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co